Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOPAZITHRO azithromycin trial in adult idiopathic purulent oedematous chronic rhinosinusitis
2024-517239-33-00Phase 3Completed
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Comparison of sinonasal outcome test (SNOT)-22 specific quality of life score averages. Started Oct 2022; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on 2024-517239-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517239-33-00.